Re:Cognition Health Study

Brain and Mind Experts

A commercial trial for the treatment of suspected early dementia with ‘donanemab’ in a clinic in Bristol.  If you feel that a patient is likely to have dementia following memory assessment in primary care, they can be considered.  They will have a PET scan, memory testing conducted.  

They need to achieve at least 20 on their MMSE to be involved (or 6CIT/GPCOG scores that demonstrate memory loss but not too significantly). 

Please speak with the Research team or Dr Streeton with any questions.